Clene Inc. (CLNN) vs eXoZymes, Inc. (EXOZ)

A side-by-side comparison of Clene Inc. and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CLNN

Clene Inc.

$50M

$3.88HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT

EXOZ

eXoZymes, Inc.

$56M

$6.03HealthcareDelayed quote: Oct 6, 2026, 10:06 AM EDT

Total return — CLNN vs EXOZ

growth of $100 · dividends reinvested · last 2y

CLNN -18.9% (-9.9%/yr)EXOZ -36.2% (-20.1%/yr)CLNN compounded faster over this window

CLNN EXOZ

CLNN vs EXOZ: by the numbers

•EXOZ is the larger company ($56M vs $50M market cap).
•Both run net losses; EXOZ's is the smaller (0.00% vs -20059.90% net margin).

Metrics side by side

Valuation

Metric	CLNN	EXOZ
P/S ratio	251.36	N/A
P/B ratio	N/A	15.32

Profitability

Metric	CLNN	EXOZ
Gross margin	78.50%	0.00%
Operating margin	-11541.50%	0.00%
Net margin	-20059.90%	0.00%
ROE	N/A	-278.89%
ROIC	-109.13%	-157.40%

Growth (annualized)

Metric	CLNN	EXOZ
Revenue CAGR (5Y)	-18.30%	N/A
Total return CAGR (5Y)	-51.16%	N/A

Go deeper

Full CLNN analysis Full EXOZ analysis Interactive comparison tool

Dig into the metrics

Clene ROE eXoZymes ROE Clene operating margin eXoZymes operating margin Clene revenue growth eXoZymes revenue growth Clene free cash flow eXoZymes free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.